99% Melanotan-II Powder CAS 121062-08-6 Factory Skin Tanning Melanotan-II

Name: 99% Melanotan-II Powder CAS 121062-08-6 Factory Skin Tanning Melanotan-II
Brand: Xi'an Xinlu Biotechnology Co., Ltd.
SKU: wnaRYWbTserH
Price: 200.00 USD
Availability: InStock

Send Inquiry

Chat Now

Still deciding? Get samples of $ !

Request Sample

Product Details

Customization:	Available
Powder:	Yes
Customized:	Customized

Xi'an Xinlu Biotechnology Co., Ltd.

360° Virtual Tour

Shaanxi, China

Rating

4.9

Diamond Member Since 2024

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

In-stock Capacity

The supplier has In-stock capacity

Fast Delivery

The supplier can deliver the goods within 15 days

OEM Services

The supplier provides OEM services for popular brands

R&D Capabilities

The supplier has 1 R&D engineers, you can check the Audit Report for more information

to see all verified strength labels (13)

99% Melanotan-II Powder CAS 121062-08-6 Factory Skin Tanning Melanotan-II pictures & photos

Find Similar Products

Product Description

Company Info.

Basic Info.

Model NO.: A126
Certification: GMP, HSE, ISO 9001, USP, BP
Suitable for: Adult
State: Powder
Purity: >99%
Name: Melanotan-II
Appearance: White Powder
Assay: 99%
CAS: 121062-08-6
OEM: Available
Sample: Available
Suitable: Adult
Function: Skin Tanning
Transport Package: Foil Bag
Specification: 99
Trademark: /
Origin: China
Production Capacity: 10000 Kgs Per Month

Product Description

99% Melanotan-II Powder CAS 121062-08-6 Factory Skin Tanning Melanotan-II

Product Name	Melanotan-II
Appearance	White Powder
CAS NO.	121062-08-6
Molecular Formula	C50H69N15O9
Storage	Keep in a cool, dry, dark location

Melanotan-II is a synthetic analog of the peptide hormone α-melanocyte-stimulating hormone (α-MSH). It acts as a potent agonist for melanocortin receptors, particularly the MC1R subtype, which are responsible for regulating pigmentation in the skin. By stimulating the MC1R receptor, Melanotan-II promotes the production and distribution of melanin, the pigment that gives skin its color. This results in a tanning effect similar to that achieved through natural sun exposure but without the associated risks of UV radiation. Additionally, Melanotan-II has been studied for potential therapeutic applications in areas such as erythropoietic protoporphyria and may hold promise for enhancing the effectiveness of certain cancer therapies, although these uses are still under investigation and not yet approved for clinical use.

99% Melanotan-II Powder CAS 121062-08-6 Factory Skin Tanning Melanotan-II

Skin Tanning: Melanotan-II is primarily used by individuals seeking an alternative to traditional sun exposure for achieving a tanned complexion. It stimulates the production of melanin, the pigment that gives skin its color, thereby mimicking the effects of UV radiation without the harmful side effects.
Photoprotection: By increasing melanin levels, Melanotan-II can potentially offer a degree of photoprotection, reducing the risk of sunburn and potentially lowering the long-term risk of skin cancer associated with UV radiation exposure.
Medical Research: It is also utilized in medical research settings to study the mechanisms of pigmentation, skin cancer development, and the role of melanin in various physiological processes.

Stimulates Melanogenesis: The primary function of Melanotan-II is to activate the melanocortin 1 receptor (MC1R) on melanocytes, the cells responsible for producing melanin. This activation triggers the synthesis and distribution of melanin throughout the skin, leading to increased pigmentation.
Modulates Skin Color: By enhancing melanogenesis, Melanotan-II modulates skin color, causing a darker, more tanned appearance. This effect is desired by some individuals for cosmetic purposes or as a means of achieving a more uniform skin tone.
Potential Therapeutic Applications: Beyond cosmetic use, there is ongoing research exploring the potential of Melanotan-II and related compounds in the treatment of various conditions, such as erythropoietic protoporphyria (a rare skin disorder causing sensitivity to sunlight) and potentially in enhancing the effectiveness of certain cancer therapies that rely on melanin-producing cells. However, these applications are still under investigation and not yet approved for clinical use.